Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

FDMT

4D Molecular Therapeutics, Inc.

CIK 0001650648 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$15.83
↓ 0.27 (-1.68%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$874.51M
P/E Ratio
-4.88
EPS
-2.42
Dividend Yield
Not covered
52W Position
90%
Beta
1.92

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.15
P/S
9.50
EV/Revenue
8.95
ROE
-44.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 90%
$5.97$16.93

Latest Financials

2025-12-31 FY
Revenue
$85.21M
Net Income
-$140.11M
Total Assets
$566.71M
Free Cash Flow
-$109.62M

Recent news